Consensus document for the management of tuberculosis in solid organ transplant recipients;Documento de consenso para el tratamiento de la tuberculosis en pacientes con trasplante de órgano sólido

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 27, Issue 8, 2009, Pages 465-473

  Aguado, José María ^a   Torre Cisneros, Julián ^b   Fortún, Jesús ^c   Benito, Natividad ^d   Meije, Yolanda ^a   Doblas, Antonio ^b   Muñoz, Patricia ^e  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^c HOSPITAL RAMÓN Y CAJAL   (Spain)

^d HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^e HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Mycobacterium tuberculosis; Solid organ transplantation; Tuberculosis

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; CYCLOSPORIN A; ETHAMBUTOL; ISONIAZID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISONE; PYRAZINAMIDE; PYRIDOXINE; RAPAMYCIN; RIFABUTIN; RIFAMPICIN; STEROID; TACROLIMUS;

CONSENSUS; GRAFT REJECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MORTALITY; MYCOBACTERIUM TUBERCULOSIS; ORGAN TRANSPLANTATION; PROPHYLAXIS; REVIEW; RISK FACTOR; TREATMENT DURATION; TUBERCULOSIS;

EID: 70349443258     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/j.eimc.2008.10.008     Document Type: Article

References (53)

1. J.M. Aguado, J.A. Herrero, J. Gavaldá, J. Torre-Cisneros, M. Blanes, and G. Rufí Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain Transplantation 63 1997 1278 1286
2. P. Muñoz, C. Rodríguez, and E. Bouza Mycobacterium tuberculosis infection in recipients of solid organ transplants Clin Infect Dis 40 2005 581 587
3. N. Singh, and D.L. Paterson Mycobacterium tuberculosis infection in solid-organ transplant recipients: Impact and implications for management Clin Infect Dis 27 1998 1266 1277
4. Green M, Avery RK, Preiksaitis J, editors. Guidelines for the prevention and management of infectious complications of solid organ transplantation. Am J Transplant 2004;4 Suppl 10:37-41.
5. M.A. Kish Guide to development of practice guidelines Clin Infect Dis 32 2001 851 854
6. P.A. Gross, T.L. Barrett, P. Dellinger, P.J. Krause, W.J. Martone, and J.E. McGowan Jr Purpose of quality standars for infectious diseases. Infectious Diseases Society of America Clin Infect Dis 18 1994 421
7. A. Basiri, S.M.M. Hosseini Moghaddam, N. Simforoosh, B. Einollahi, M. Hosseini, and A. Foirouzan Preliminary report of nationwide case-control study for identifying risk factors of tuberculosis following renal transplantation Transplant Proc 37 2005 3041 3044
8. J. Torres, J.M. Aguado, R. San Juan, A. Andrés, P. Sierra, and F. López-Medrano Hepatitis C virus, an important risk factor for tuberculosis in immunocompromised: Experience with kidney transplantation Transpl Int 21 2008 873 878
9. G.T. John, V. Shankar, A.M. Abraham, U. Mukundan, P.P. Thomas, and C.K. Jacob Risk factors for post-trasplant tuberculosis Kidney Int 60 2001 1148 1153
10. N. Benito, O. Sued, A. Moreno, J.P. Horcajada, J. González, and M. Navasa Diagnosis and treatment of latent tuberculosis infection in liver transplant recipients in an endemic area Transplantation 74 2002 1381 1386
11. J. Ayats-Ardite, J.M. Cisneros-Herreros, and J.L. Pérez- Sáenz Evaluación de las enfermedades infecciosas en el candidato a un trasplante de órgano sólido Enferm Infecc Microbiol Clin 20 2002 448 461
12. Green M, Avery RK, Preiksaitis J, editors. Guidelines for the prevention and management of infectious complications of solid organ transplantation. Am J Transplant 2004;4 Suppl 10:164-166.
13. J. Torre-Cisneros, J.J. Castón, and J. Moreno Tuberculosis in the transplant candidate: Importance of the early diagnosis and treatment Transplantation 77 2004 1376 1380
14. a ed 2004 Elsevier Madrid 191 211
15. a ed. Noviembre 2004. Disponible en: http://www.seimc.org/gesitra/ dyc205.doc
16. H.M. Blumberg, W.J. Burman, R.E. Chaisson, C.L. Daley, S.C. Etkind, and L.N. Friedman American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: Treatment of tuberculosis Am J Respir Crit Care Med 167 2003 603 662
17. J.C. Graham, A.M. Kearns, J.G. Magee, M.F. El-Sheikh, M. Hudson, and D. Manas Tuberculosis transmitted through transplantation J Infect 43 2001 251 254
18. E. Hernández-Hernández, J. Alberu, L. González- Michaca, M. Bobadilla del Valle, R. Correa-Rotter, and J. Sifuentes-Osornio Screening for tuberculosis in the study of the living renal donor in a developing country Transplantation 81 2006 290 292
19. P. Muñoz, J. Palomo, R. Muñoz, M. Rodríguez-Creixems, T. Pelaez, and E. Bouza Tuberculosis in heart transplant recipients Clin Infect Dis 21 1995 398 402
20. H. Riska, C. Gronhagen-Riska, and J. Ahonen Tuberculosis and renal allograft transplantation Transplant Proc 19 1987 4096 4097
21. G.T. John, P.P. Thomas, M. Thomas, L. Jeyaseelan, C.K. Jacob, and J.C. Shastry A double-blind randomized controlled trial of primary isoniazid prophylaxis in dialysis and transplant patients Transplantation 57 1994 1683 1684
22. A. Varela, A. Álvarez Kindelan, A. Roman, P. Ussetti, and F. Zurbano Trasplante pulmonar. Grupo de Trabajo de la SEPAR (Guías de la Sociedad Española de Patología del Aparato Respiratorio) Arch Bronconeumol 37 2001 307 315
23. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.7.2. Late infections. Tuberculosis. Nephrol Dial Transplant. 2002;17:39-43.
24. A. Roman, C. Bravo, G. Levy, V. Monforte, R. Vidal, and J. Sole Isoniazid prophylaxis in lung transplantation J Heart Lung Transplant 19 2000 903 906
25. S. Vikrant, S.K. Agarwal, S. Gupta, D. Bhowmik, S.C. Tiwari, and S.C. Dash Prospective randomized control trial of isoniazid chemoprophylaxis during renal replacement therapy Transpl Infect Dis 7 2005 99 108
26. S.K. Agarwal, S. Gupta, S.C. Dash, D. Bhowmik, and S.C. Tiwari Prospective randomised trial of isoniazid prophylaxis in renal transplant recipient Int Urol Nephrol 36 2004 425 431
27. S.L. Lui, F.K. Li, B.Y. Choy, T.M. Chan, W.K. Lo, and K.N. Lai Long-term outcome of isoniazid prophylaxis against tuberculosis in Chinese renal transplant recipients Transpl Infect Dis 6 2004 55 56
28. S.J. Antony, C. Ynares, and J.S. Dummer Isoniazid hepatotoxicity in renal transplant recipients Clin Transplant 11 1997 34 37
29. K. Sud, T. Muthukumar, B. Singh, S.K. Garg, H.S. Kohli, and V. Jha Isoniazid does not affect bioavailability of cyclosporine in renal transplant recipients Methods Find Exp Clin Pharmacol 22 2000 647 649
30. American Thoracic Society Targeted tuberculin testing and treatment of latent tuberculosis infection MMWR Recomm Rep 49 2000 1 51
31. C.R. Horsburgh Jr, S. Feldman, and R. Ridzon Practice guidelines for the treatment of tuberculosis Clin Infect Dis 31 2000 633 639
32. D. Yee, C. Valiquette, M. Pelletier, I. Parisien, I. Rocher, and D. Menzies Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis Am J Respir Crit Care Med 167 2003 1472 1477
33. N. Singh, M.M. Wagener, and T. Gayowski Safety and efficacy of isoniazid chemoprophylaxis administered during liver transplant candidacy for the prevention of posttransplant tuberculosis Transplantation 74 2002 892 895
34. Z. Taylor, C.M. Nolan, and H.M. Blumberg Controlling tuberculosis in the United States. Recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America MMWR Recomm Rep 54 2005 1 81
35. A. Sayiner, T. Ece, S. Duman, A. Yildiz, M. Ozkahya, and Z. Kilicaslan Tuberculosis in renal transplant recipients Transplantation 68 1999 1268 1271
36. M.H. Al-Sulaiman, J.M. Dhar, and A.A. Al-Khader Successful use of rifampicin in the treatment of tuberculosis in renal transplant patients immunosuppressed with cyclosporine Transplantation 50 1990 597 598
37. EBPG Expert Group on renal transplantation. Nephrol Dial Transplant. 2002;17 Suppl 4:39-43.
38. C. Dromer, S.A. Nashef, J.F. Velly, C. Martigne, and L. Couraud Tuberculosis in transplanted lungs J Heart Lung Transplant 12 1993 924 927
39. G. Offermann, F. Keller, and M. Molzahn Low cyclosporin A blood levels and acute graft rejection in a renal transplant recipient during rifampin treatment Am J Nephrol 5 1985 385 387
40. A. López-Montes, E. Gallego, E. López, J. Pérez, I. Lorenzo, and F. Llamas Treatment of tuberculosis with rifabutin in a renal transplant recipient Am J Kidney Dis 44 2004 e59 e63
41. J. Lee, W.W. Yew, C.F. Wong, P.C. Wong, and C.S. Chiu Multidrug-resistant tuberculosis in a lung transplant recipient J Heart Lung Transplant 22 2003 1168 1173
42. C. Vandevelde, A. Chang, D. Andrews, W. Riggs, and P. Jewesson Rifampin and ansamycin interactions with cyclosporine after renal transplantation Pharmacotherapy 11 1991 88 89
43. R.J. O'Brien Development of fluoroquinolones as first-line drugs for tuberculosis-at long last! Am J Respir Crit Care Med 168 2003 1266 1268
44. A.S. Ginsburg, J.H. Grosset, and W.R. Bishai Fluoroquinolones, tuberculosis, and resistance Lancet Infect Dis 3 2003 432 442
45. H.X. Lou, M.A. Shullo, and T.P. McKaveney Limited tolerability of levofloxacin and pyrazinamide for multidrug-resistant tuberculosis prophylaxis in a solid organ transplant population Pharmacotherapy 226 2002 701 704
46. J. Fortun, P. Martín-Dávila, E. Navas, M.J. Pérez-Elias, J. Cobo, and M. Tato Linezolid for the treatment of multidrug-resistant tuberculosis J Antimicrob Chemother 56 2005 180 185
47. S.J. Antony, C. Ynares, and J.S. Dummer Isoniazid hepatotoxicity in renal transplant recipients Clin Transplant 11 1997 34 37
48. L.K. Schluger, P.A. Sheiner, M. Jonas, J.V. Guarrera, I.M. Fiel, and B. Meyers Isoniazid hepatotoxicity after orthotopic liver transplantation Mt Sinai J Med 63 1996 364 369
49. B.R. Meyers, G.A. Papanicolaou, P. Sheiner, S. Emre, and C. Miller Tuberculosis in orthotopic liver transplant patients: Increased toxicity of recommended agents; cure of disseminated infection with nonconventional regimens Transplantation 69 2000 64 69
50. D. Kunimoto, A. Warman, A. Beckon, D. Doering, and L. Melenka Severe hepatotoxicity associated with rifampin-pyrazinamide preventative therapy requiring transplantation in an individual at low risk for hepatotoxicity Clin Infect Dis 36 2003 e158 e161
51. J.M. Miró, J. Torre-Cisneros, and A. Moreno Documento de consenso GESIDA/GESITRA-SEIMC, SPNS y ONT sobre trasplante de órgano sólido en pacientes infectados por el VIH en España (marzo 2005) Enferm Infecc Microbiol Clin 23 2005 353 362
52. J.M. Miró, F. Agüero, and M. Laguna Liver transplantation in HIV/hepatitis co-infection J HIV Ther 12 2007 24 35
53. Y.S. Park, J.Y. Choi, C.H. Cho, K.H. Chang, Y.G. Song, and Y.S. Kim Clinical outcomes of tuberculosis in renal transplant recipients Yonsei Med J 45 2004 865 872